Leiomyosarcoma of the pancreas is an extremely rare mesen chymal tumor, less than 50 cases have been reported till now. It accounts for 0.1% of pancreatic malignancy. Prognosis of this tumor is very poor, fewer are in resectable state. Surgical resection is the best possible option if feasible. We are reporting a case of leiomyosarcoma of pancreas underwent laparoscopic distal pancreatosplenectomy.
IntroDuctIon
Leiomyosarcoma of pancreas is an extremely rare mesen chymal tumor, less than 50 cases have been reported till now. 1 It accounts for 0.1% of pancreatic malignancy. 2 Prognosis of this tumor is very poor, 3 fewer are in resectable state.
Surgical resection is the best possible option if feasible. We are reporting a case of leiomyosarcoma of pancreas under went laparoscopic distal pancreatosplenectomy.
cASe rePort
A 78yearold gentleman visited our institution with com plaint of pain at left upper quadrant of abdomen for 2 years with significant weight loss of 10 kg over a period of last 6 months and occasional vomiting. Examination revealed deep tenderness in left hypochondrium, no palpable mass or any other findings noted. Further evaluation in form of contrast enhanced computed tomography (Fig. 1A ) of abdomen revealed heterogeneously enhancing soft tissue lesion in distal body and tail of pancreas with solid and cystic com ponents. Splenic vessels were encased within the tumor.
Fat planes with surrounding organs were preserved. He underwent laparoscopic distal pancreatectosplenectomy, the specimen was retrieved within the Endobag from the Pfannenstiel incision (Figs 1B and C). The procedure took 177 minutes with around 100 cc of blood loss. Postoperative recovery was uneventful and was discharged on post operative day 6. Histopathological examination of specimen revealed intermediate grade leiomyosarcoma. All the margins and lymphnodes were free of tumor and there was no lymphovascular involvement (Figs 2A to C). Immuno histochemistry examination showed tumor cells positive for smooth muscle actin (SMA) and h-Caldesmon. Now with 6 months of followup, patient is doing well without any recurrence or complications.
DIScuSSIon
Mesenchymal tumor of pancreas are extremely rare, as of now less than 50 cases of pancreatic leiomyosarcoma have been reported in literature, 1 many of them had metastatic tumor. Literature suggests that it usually occurs in patients over 50 years of age, 4 as it was in our case. Origin of these mesenchymal tumor is usually pancreatic duct or blood vessels within the pancreas. 5 These tumors more commonly arise in the body and tail of the pancreas 5 which was seen in our patient also. It usually metastatize via hematogenous route and common site of metastasis are lung, liver, brain and spine. 1 Surgery is the preferred treatment for pancreatic leiomyosarcoma which offers the best survival. There are very few cases of laparoscopic distal pancreatosplenectomy reported for leiomyosarcoma in literature. Due to the mag nification of vision we feel that oncological clearance is better with the laparoscopic approach. We did not find any difficulty while laparoscopic resection. Literature support laparoscopic distal pancreatectomy over open distal pan createctomy for benign and low grade malignant tumors but the experience for high grade malignant is limited and needs longterm data. 6 Histopathological examination revealed pancreatic leiomyosarcoma. Most leiomyosarcomas are positive for SMA, desmin, cadesmon and vimentin. 1 In our case, the tumor was positive for SMA and h-Caldesmon.
concLuSIon
Pancreatic leiomyosarcoma is very rare tumor with poor prognosis. Although, it is too early to recommend but lapa roscopic resection of this tumor is feasible. 
